PharmaShots Weekly Snapshot (April 01-05, 2019)

Amazon Launches Alexa’s Health Services for Managing Health and Handling Patients Data

Published: April 05, 2019 | Tags: Amazon, Launches, Alexa, Health Services, Managing Health, Handling Patients Data

Roivant Launches Cytovant Sciences to Collaborates with Medigene for the Development of Cellular Therapies in Asia

Published: April 05, 2019 | Tags: Roivant, Launches, Cytovant Sciences, Collaborates, Medigene, Development, Cellular Therapies, Asia

 Abbott Signs a Non-Exclusive License Agreement with Banyan Biomarkers for its Traumatic Brain Injury (TBI) Blood Biomarkers

Published: April 05, 2019 | Tags: Abbott, Signs, Non-Exclusive, License Agreement, Banyan, Traumatic Brain Injury, TBI, Biomarkers

Myriad Expands its Companion Diagnostic Collaboration with AstraZeneca and Merck

Published: April 05, 2019 | Tags: Myriad, Expands, Companion Diagnostic, Collaboration, AstraZeneca, Merck

Oncology Venture Signs an Exclusive Option Agreement to In-License Commercialization Rights for R-Pharm’s Ixempra (ixabepilone) in EU

Published: April 05, 2019 | Tags: Oncology Venture,Signs, Exclusive, Option, Agreement, In-License, Commercialization, Rights, R-Pharm, Ixempra, ixabepilone, EU, Metastaic Breast Cancer

AstraZeneca and the US NIAID Report Results of Fasenra (benralizumab) in P-II Study for Hypereosinophilic Syndromes (HES)

Published: April 04, 2019 | Tags: AstraZeneca, Fasenra, benralizumab, Receives, FDA, Approval, Hypereosinophilic Syndromes, HES

Genmab and Janssen Biotech Report Initiation of P-III MMY3021 Study for Darzalex (daratumumab) in Multiple Myeloma

Published: April 04, 2019 | Tags:Genmab, Janssen Biotech, Report, Initiation, P-III, MMY3021 Study, Daratumumab, Multiple Myeloma

Editas Medicine Signs a Research and Cross-Licensing Agreement with BlueRock Therapeutics for their Technologies

Published: April 04, 2019 | Tags: Editas, Medicine, Signs, Research, Cross-Licensing Agreement, BlueRock Therapeutics, Combine; Genome Editing, Cell Therapy Technology

Fresenius Kabi’s Idacio (adalimumab, biosimilar) Receives EU’s Marketing Approval in Rheumatology, Gastroenterology and Dermatology

Published: April 04, 2019 | Tags: Fresenius Kabi, Idacio, adalimumab, biosimilar, Receives, EU, Marketing Approval, Rheumatology, Gastroenterology, Dermatology

Liquidia Reports Results of LIQ861 in P-III INSPIRE Trial in Patients with Pulmonary Arterial Hypertension (PAH)

Published: April 04, 2019 | Tags: Liquidia, Reports, Results, LIQ861, P-III, INSPIRE trial, Patients, Pulmonary Arterial Hypertension, PAH

Channel Medsystems’ Cerene Cryotherapy Device Receives FDA’s Approval for Heavy Menstrual Bleeding

Published: April 03, 2019 | Tags: Channel Medsystems, Cerene Cryotherapy Device, Receives, FDA, Approval, Heavy Menstrual Bleeding

Dermelix Collaborates with EspeRare to Co-develop and Commercialize DMX-101 for XLHED

Published: April 03, 2019 | Tags: Dermelix, Collaborates, EspeRare, Co-develop, Commercialize, DMX-101, XLHED

Encore Dermatology to Acquire US Commercialization Rights for Dr. Reddy’s Three Dermatology Products

Published: April 03, 2019 | Tags: Encore Dermatology, Acquire, US, Commercialization Rights, Dr. Reddy, Three, Dermatology, Products

Astellas Signs a Research and License Agreement with Xencor for Bispecific Antibody Program in Oncology

Published: April 03, 2019 | Tags: Astellas, Signs, Research Agreement, Xencor, Novel, Bispecific, Antibody,Program

Allergan and Molecular Partners Report Result of Abicipar pegol in P-III MAPLE Study for Neovascular Macular Degeneration (nAMD)

Published: April 03, 2019 | Tags: Allergan, Molecular Partners, Report, Result, Abicipar pegol, P-III, MAPLE Study, Neovascular Macular Degeneration, nAMD

Sangamo Therapeutics Signs an Option Agreement with Brammer Bio for its AAV Manufacturing Facility

Published: April 02, 2019 | Tags: Sangamo Therapeutics, Signs, Option, Agreement, Brammer Bio, AAV, Manufacturing, Facility

Novartis’ Cosentyx (secukinumab) Receives NMPA’s (CFDA) Approval for Patients with Plaque Psoriasis in Adults

Published: April 02, 2019 | Tags: Novartis, Cosentyx, secukinumab, Receives, NMPA, CFDA, Approval, Patients, Psoriasis

Merck’s Keytruda (pembrolizumab) + Chemotherapy Receive NMPA’s (CFDA) Approval for 1L Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Published: April 02, 2019 | Tags: Merck; Keytruda; pembrolizumab; Chemotherapy; Receive; NMPA; CFDA; Approval; 1L; Metastatic; Non-Squamous; Non-Small Cell Lung Cancer; NSCLC

AveXis to Purchase Biologics Manufacturing Facility in Colorado

Published: April 02, 2019 | Tags: AveXis, Purchase, Biologics, Therapy, Manufacturing Facility, Longmont, Colorado

VistaGen Therapeutics Reports Positive Results of PH94B in P-III study for Social Anxiety Disorder (SAD)

Published: April 02, 2019 | Tags: VistaGen; Reports; Positive; Results; PH94B; P-III; Social Anxiety Disorder; SAD

Roche Reports Result of Ipatasertib + Tecentriq (atezolizumab) in P-Ib Study for 1L Patients with Advanced Triple-Negative Breast Cancer (TNBC)

Published: April 01, 2019 | Tags: Roche, Reports, Results, Ipatasertib, Tecentriq, atezolizumab, P-Ib, Study, 1L Patients, Advanced Triple-Negative Breast Cancer, TNBC

Boehringer Ingelheim (BI) to Acquire ICD Therapeutics for its MacroDel Delivery Technology

Published: April 01, 2019 | Tags: Boehringer Ingelheim, Acquires, ICD Therapeutics, Novel MacroDel Delivery Technology

Novartis to Acquire IFM Tre for its Clinical and Preclinical Portfolio of NLRP3 Inhibitors for $1.5B

Published: April 01, 2019 | Tags: Novartis, Acquire, IFM Tre, NLRP3 Inhibitors, Portfolio

Bluebird Bio’s Zynteglo Receives CHMP’s Positive Opinion for Conditional Marketing for Patients with Transfusion-Dependent β-Thalassemia (TDT) without β0/β0 Genotype

Published: April 01, 2019 | Tags: Bluebird Bio, Zynteglo, Receives, CHMP, Positive Opinion, Conditional Marketing, Patients, Transfusion-Dependent β-Thalassemia, TDT, Without, β0/β0 Genotype

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post